Proposal to continue with the current provider for storage and distribution services for funded pharmaceuticals
Pharmac proposes retaining Onelink to store and distribute funded condoms, nicotine-replacement products and naloxone, and adding logistics for the hepatitis C medicines Harvoni and ribavirin.
- Closing date
- 24 July 2026
- Added to Civics
- 13 July 2026
- Source category
- Other public body
- Source body
- Pharmaceutical Management Agency
- Last checked
- 13 July 2026
Closes in 10 days
Plain-English summary
Following a competitive procurement process, Pharmac proposes retaining Onelink to store and distribute funded condoms, nicotine-replacement products and naloxone to community health organisations. The contract would also cover logistics for Harvoni and ribavirin, which treat hepatitis C.
Pharmac expects no change to existing ordering or delivery arrangements. The proposed contract would run to June 2028, with two possible one-year extensions, and feedback is sought on any effects for patients, providers and suppliers.
Why it matters
The contract supports direct access to funded sexual-health, smoking-cessation and overdose-response products through community organisations.
It also covers the specialist supply chain used to deliver two funded hepatitis C medicines.
Who may care
- Community health providers, pharmacies, infectious-disease services and medicine suppliers
- People who use the funded products and health-sector advocacy organisations
How to make a submission
- Complete the online form linked from the official consultation page.
- Alternatively, email procurement@pharmac.govt.nz before 4pm on the closing date.
Disclaimer
Civics.nz is an independent plain-English guide and is not an official government website. Always check the official source before making a submission.